Peta-Anne Paul-Brent
Overview
Explore the profile of Peta-Anne Paul-Brent including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
129
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hudson R, Pascoe E, See Y, Cho Y, Polkinghorne K, Paul-Brent P, et al.
J Vasc Access
. 2022 Jun;
25(1):193-202.
PMID: 35686506
Aim: To describe and compare de novo arteriovenous fistula (AVF) failure rates between Australia and New Zealand (ANZ), and Malaysia. Background: AVFs are preferred for haemodialysis access but are limited...
2.
See Y, Cho Y, Pascoe E, Cass A, Irish A, Voss D, et al.
Kidney360
. 2022 Apr;
1(11):1259-1269.
PMID: 35372875
Background: An autologous arteriovenous fistula (AVF) is the preferred hemodialysis vascular access, but successful creation is hampered by high rates of AVF failure. This study aimed to evaluate patient and...
3.
Conley M, Barden A, Viecelli A, Irish A, Cass A, Hawley C, et al.
J Hum Nutr Diet
. 2021 Dec;
35(6):1178-1191.
PMID: 34921448
Background: Dietary management plays an important role in patients with kidney failure. Current dietary habits of Australians and New Zealanders (ANZ) and Malaysians with chronic kidney disease (CKD Stage 4-5)...
4.
Robison L, Cho Y, Viecelli A, Johnson D, Hawley C, Valks A, et al.
Trials
. 2021 Apr;
22(1):278.
PMID: 33853661
The unprecedented demand placed on healthcare systems from the COVID-19 pandemic has forced a reassessment of clinical trial conduct and feasibility. Consequently, the Australasian Kidney Trials Network (AKTN), an established...
5.
Tiong M, Krishnasamy R, Smith E, Hutchison C, Ryan E, Pascoe E, et al.
Hemodial Int
. 2021 Mar;
PMID: 33779046
Introduction: Hemodialysis (HD) with medium cut-off (MCO) dialyzers may expand molecular clearance, predominantly larger middle molecules (molecular weight 25-60 kDa). However, the impact of MCO dialyzers on long-term clearance of...
6.
Chow J, Adams K, Cho Y, Choi P, Equinox K, Figueiredo A, et al.
Perit Dial Int
. 2020 Feb;
40(2):153-163.
PMID: 32063194
Background: There is substantial variation in peritonitis rates across peritoneal dialysis (PD) units globally. This may, in part, be related to the wide variability in the content and delivery of...
7.
Krishnasamy R, Hawley C, Jardine M, Roberts M, Cho Y, Wong M, et al.
Blood Purif
. 2020 Jan;
49(4):468-478.
PMID: 31968346
Background: A new class of dialysis membrane, the mid cut-off (MCO) dialyzer, has been developed to improve the clearance of uremic toxins in hemodialysis (HD). The a tRial Evaluating Mid...
8.
Viecelli A, Polkinghorne K, Pascoe E, Paul-Brent P, Hawley C, Badve S, et al.
PLoS One
. 2019 Mar;
14(3):e0213274.
PMID: 30913208
Background: Arteriovenous fistulas (AVF) for haemodialysis often experience early thrombosis and maturation failure requiring intervention and/or central venous catheter (CVC) placement. This secondary and exploratory analysis of the FAVOURED study...
9.
Irish A, Viecelli A, Hawley C, Hooi L, Pascoe E, Paul-Brent P, et al.
JAMA Intern Med
. 2017 Jan;
177(2):184-193.
PMID: 28055065
Importance: Vascular access dysfunction is a leading cause of morbidity and mortality in patients requiring hemodialysis. Arteriovenous fistulae are preferred over synthetic grafts and central venous catheters due to superior...
10.
Viecelli A, Pascoe E, Polkinghorne K, Hawley C, Paul-Brent P, Badve S, et al.
Nephrology (Carlton)
. 2016 May;
22(10):823-824.
PMID: 27188542
No abstract available.